The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors
Open accessAbstract
BACKGROUND: Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the treatment of desmoid tumors. In the current study, high doses of tamoxifen in combination with sulindac were used to treat severe desmoid tumors to avoid surgery. METHODS: Since 1992, 25 patients at Heinrich Heine University (Dusseldorf, Germany) were treated with a combination of tamoxifen and sulindac. In the current study, 17 patients with FAP‐associated and 8 patients with sporadic desmoid tumors received 120 mg of tamoxifen and 300 mg of sulindac daily. Every 6 months, the protracted course of desmoid growth was measured by computed tomography and/or magnetic resonance imaging scans. Tumor responses were characterized as progressive disease, stable disease (SD), partial regression (PR), and complete regression (CR). RESULTS: Of the group of patients who received tamoxifen and sulindac as a primary treatment, all three patients with sporadic desmoid tumors demonstrated cessation of growth, and 10 of the 13 patients with FAP‐associated tumors achieved either a PR or CR. In the sporadic desmoid tumor group, eight of nine patients developed tumor recurrences after undergoingsurgery at other institutions. Of these, two patients had SD and two patients had a PR to CR. CONCLUSIONS: The patients with desmoid tumors who were managed conservatively with high‐dose tamoxifen and sulindac had the best outcome. Desmoid tumor recurrence after surgery was high and in the FAP‐associated tumor group, therapy with tamoxifen and sulindac was found to be less successful. Based on this experience, the authors recommended high‐dose tamoxifen and sulindac as the primary treatment for patients with FAP‐associated desmoid tumors. However, to our knowledge, the best approach after surgical intervention for patients with sporadic desmoid tumors remains to be determined. Cancer 2004. © 2003 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
The Desmoid Tumor. I.: Incidence, Sex-, Age- and Anatomical Distribution in the Finnish Population
Reitamo, J. J., Häyry, P., Nykyri, E., & Saxen, E. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.6.665 · Cited by 597
Caspari, R., Olschwang, S., Friedl, W., Mandl, M., Boisson, C., Böker, T., Augustin, A. J., Kadmon, M., Möslein, G., Thomas, G. D., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.3.337 · Cited by 394
Desmoids in familial adenomatous polyposis
Clark, S. K., & Phillips, R. K. S. (1996) · Journal of British Surgery · doi:10.1002/bjs.1800831105 · Cited by 302
Friedl, W., Caspari, R., Sengteller, M., Uhlhaas, S., Lamberti, C., Jungck, M., Kadmon, M., Wolf, M., Fahnenstich, J., Gebert, J., et al. (2001) · Gut · doi:10.1136/gut.48.4.515 · Cited by 301
Individualizing management of aggressive fibromatoses
Spear, M. A., Jennings, L. C., Mankin, H. J., Spiro, I. J., Springfield, D. S., Gebhardt, M. C., Rosenberg, A. E., Efird, J. T., & Suit, H. D. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00845-6 · Cited by 277
Desmoid tumours complicating familial adenomatous polyposis
Clark, S. K., Neale, K. F., Landgrebe, J. C., & Phillips, R. K. S. (1999) · Journal of British Surgery · doi:10.1046/j.1365-2168.1999.01222.x · Cited by 255
Desmoid Tumors in Familial Polyposis Coli
JONES, I. T., FAZIO, V. W., WEAKLEY, F. L., JAGELMAN, D. G., LAVERY, I. C., & McGANNON, E. (1986) · Annals of Surgery · doi:10.1097/00000658-198607000-00014 · Cited by 209
Changing causes of mortality in patients with familial adenomatous polyposis
Belchetz, L. A., Berk, T., Bapat, B. V., Cohen, Z., & Gallinger, S. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02054051 · Cited by 168
Recent Trends in the Management of Desmoid Tumors: Summary of 19 Cases and Review of the Literature
EASTER, D. W., & HALASZ, N. A. (1989) · Annals of Surgery · doi:10.1097/00000658-198912000-00012 · Cited by 165
Hial, V., Hořáková, Z., Shaff, R. E., & Beaven, M. A. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90044-3 · Cited by 155
Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac
Belliveau, P., & Graham, A. M. (1984) · Diseases of the Colon & Rectum · doi:10.1007/bf02554079 · Cited by 78
Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors.
Gagliardi, A. R., Hennig, B., & Collins, D. C. (1996) · PubMed · Cited by 74
Breast cancer, desmoid tumours, and familial adenomatous polyposis—a unifying hypothesis
Benson, J. R., & Baum, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)92700-4 · Cited by 31
Cited by
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., Kane, J. M., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0025 · Cited by 736
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
Vasen, H. F. A., Möslein, G., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Blanco, I., Bülow, S., Burn, J., Capella, G., et al. (2008) · Gut · doi:10.1136/gut.2007.136127 · Cited by 704
Familial adenomatous polyposis
Half, E., Bercovich, D., & Rozen, P. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-22 · Cited by 596
Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.-Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P. G., van Coevorden, F., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.11.013 · Cited by 506
Desmoid Tumors: Clinical Features and Treatment Options for Advanced Disease
Kasper, B., Ströbel, P., & Hohenberger, P. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0281 · Cited by 336
Metadata
- Authors
- Hansmann, A., Adolph, C., Vogel, T., Unger, A., & Moeslein, G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-01-20
- Volume
- 100
- Issue
- 3
- Pages
- 612-620
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2018546973
- Cited by
- 357
- References
- 14
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.